Popular Articles

Blogs Comment On Supreme Court Pregnancy Leave Ruling, Obama's Notre Dame Speech, Other Topics
The following summarizes selected women"s health-related blog entries. ~ "Peaceful Revolution: Another Blow to Women," Debra Ness, Huffington Post blogs: The Supreme Court"s ruling this week in AT&T Corp. v. Hulteen "dealt a serious and painful blow to working women and the families who rely on their retirement benefits," Ness, president of the National Partnership for Women and Families, writes. The ruling "affects a limited number of people," and it "would be easy to ignore them -- easy, but terribly wrong," Ness continues. "This ruling sends a terrible message about whether discrimination will bring penalties and costs, and whether the courts will address the ongoing effects of prior discrimination," she writes. Ness notes that the ruling "couldn"t come at a worse time," adding, "In today"s grim economic climate, women and their families cannot afford to see their retirement benefits kept lower by discriminatory workplace policies that should have been remedied decades ago." Ness writes that it is "sobering that, at a time when negative stereotypes about pregnant women clearly persist, we have a Supreme Court that doesn"t stand firm for equal rights and equal opportunity." She concludes, "It"s a good reminder of what"s at stake with the Supreme Court nomination President Obama is about to make" (Ness, Huffington Post blogs, 5/21).~ "This Week in Religion and Politics," Sarah Posner, American Prospect"s "The FundamentaList": When "viewed in the context of Obama"s entire faith-based outreach project, the events" surrounding the University of Notre Dame"s commencement ceremony "highlighted how he has embraced traditionalist, conservative religion -- to the detriment of sexual and reproductive justice," Posner writes. President Obama has "focused his outreach efforts" to reduce the need for abortion "on more conservative religious groups" and "claims to honor their position on moral issues," Posner writes. However, "when the dust settles on the Notre Dame controversy, he"ll have to figure out what to do with the policy advice he has sought" from the White House Office on Faith-Based and Neighborhood Partnerships, she continues. Posner adds, "How Obama reacts to that advice will demonstrate whether the council is mere window dressing to shore up support from swing constituencies or whether Obama will yield to conservative religious dogma on reproductive-health issues." Meanwhile, Christian conservatives have been "making hay of the findings" of recent Pew and Gallup polls that found more U.S. residents identifying with "pro-life" positions and using the data to argue "that Obama"s position is out of touch with the majority of Americans," Posner writes. However, as bloggers at The Monkey Cage and FiveThirtyEight have pointed out, the polls are not representative of most U.S. residents" views on abortion rights, she writes. "Because of that deception on reproductive rights, it"s more important than ever for the president to lay the moral groundwork for his own position -- not just to recognize the moral qualms of abortion opponents," Posner says (Posner, "The FundamentaList," American Prospect, 5/20).~ "Meghan McCain Preaches What She Practices," Willa Paskin, Slate"s "XX Factor": Meghan McCain -- Sen. John McCain"s (R-Ariz.) daughter -- "acquitted herself quite admirably" on Monday"s episode of Comedy Central"s "The Colbert Report" by "defending her core position" that the Republican Party "needs to appeal to younger voters, and it can only do so by getting liberal on social issues," Paskin writes. On the show, McCain said, "I think it"s not realistic for this generation to be just plain abstinent, I think we need to have sex education with condoms and birth control. ... I would never practice anything I didn"t preach." Paskin also includes a video clip of McCain"s appearance (Paskin, "XX Factor," Slate, 5/19).~ "Skill the Messenger," Cristina Page, Birth Control Watch: Alaska Gov. Sarah Palin"s (R) 18-year-old daughter Bristol -- who was

Los Angeles County Health Officials Release Report On HIV In Adult Film Industry
Twenty-two people in the adult film industry have tested positive for HIV in the last five years in Los Angeles County, according to a new report released on Thursday by county health officials, the Los Angeles Times reports. Officials were prompted to release the report after an adult film star last week tested positive for HIV. An outbreak occurred in 2004, in which at least five people tested positive for HIV, and caused the industry to shut down for one month. The cases in 2004 prompted a series of public hearings over the years that sought to require the industry to adopt safer practices, but no legislation was introduced. "The report ò€¦ is bringing renewed scrutiny to the estimated $12-billion-a-year industry"s long history of resisting regulation and condom use," according to the Times. Michael Weinstein, president of the Los Angeles-based AIDS Healthcare Foundation, said, "This industry screams for regulation," adding that the California Division of Occupational Safety and Health "needs to require that condoms be used in any film." Sharon Mitchell, co-founder of the Adult Industry Medical Healthcare Foundation, the clinic which tests people in the adult film industry for sexually transmitted infections, said the clinic promotes HIV prevention and testing, but added "we are not the police department of the industry nor wish to be" (Yoshino/Rong-Gong, Los Angeles Times, 6/12).
News of the day
Carbon Monoxide Prevents Clotting
Researchers led by Drs. James F. George and Anupam Agarwal at the University of Alabama at Birmingham have found that carbon monoxide (CO) can protect against arterial clotting. They report their data in the July 2009 issue of the American Journal of Pathology.
Public Health

Advanced Life Sciences Announces Outcome Of FDA's Anti-Infective Drugs Advisory Committee Review Of Restanza(TM) (cethromycin)

Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) announced that the FDA"s Anti-Infective Drugs Advisory Committee voted in the majority that Restanza(TM) (cethromycin) demonstrated safety for the outpatient treatment of adults with mild-to-moderate community acquired pneumonia (CAP) (11 positive, 3 negative, 1 abstaining). However, the committee voted that Restanza did not demonstrate efficacy in the treatment of CAP (3 positive, 11 negative, 1 abstaining). "We believe in Restanza"s potential and remain committed to its development. We were particularly encouraged by the supportive comments of several members of the committee relative to their positive review of the safety profile of Restanza, the therapeutic need for more effective treatments for CAP and their interest in seeing the company pursue further development," said Dr. Michael Flavin, Chairman and CEO of Advanced Life Sciences. "As we have throughout the review process we will continue to work closely with the FDA as they complete their assessment of the Restanza new drug application (NDA)." Although it is not binding, the Committee"s recommendation will be considered by the FDA as it completes its review of Restanza"s NDA in CAP. The FDA has established a Prescription Drugs User Fee Act (PDUFA) date of July 31, 2009 for the Restanza NDA. About Restanza Restanza is a novel, once-a-day, oral antibiotic that is under review for approval by the FDA for the treatment of CAP. It has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, it appears to be effective against penicillin-, macrolide-, and fluoroquinolone-resistant bacteria. Restanza"s demonstrated potency and ability to overcome bacterial resistance may be due to its mechanism of action resulting in specificity for its bacterial target. In addition to its utility in CAP, Restanza is also being investigated for the prophylactic treatment of inhalation anthrax post-exposure. The FDA has designated Restanza as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the drug is not yet approved for this or any other indication. About Community Acquired Pneumonia (CAP) CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. CAP affects 5.6 million patients in the United States each year, with 10 million physician visits and 2 million hospitalizations occurring annually. Macrolides and penicillins are currently the front-line treatments for respiratory tract infections such as CAP. As macrolide and penicillin resistance grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance. About Advanced Life Sciences Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer, respiratory diseases and biodefense. Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in Advanced Life Sciences" filings with the Securities and Exchange Commission. Advanced Life Sciences undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise. Advanced Life Sciences Holdings, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):